Cargando…
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury
Thromboxane A2 receptor (TXA2R) activation is thought to be involved in thrombosis/hemostasis and inflammation responses. We have previously shown that TXA2R antagonist SQ29548 attenuates BV2 microglia activation by suppression of ERK pathway, but its effect is not tested in vivo. The present study...
Autores principales: | Yan, Aijuan, Zhang, Tingting, Yang, Xiao, Shao, Jiaxiang, Fu, Ningzhen, Shen, Fanxia, Fu, Yi, Xia, Weiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075919/ https://www.ncbi.nlm.nih.gov/pubmed/27775054 http://dx.doi.org/10.1038/srep35885 |
Ejemplares similares
-
Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS-induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF-κB signaling pathways
por: Yan, Aijuan, et al.
Publicado: (2017) -
Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor
por: Chakraborty, Raja, et al.
Publicado: (2014) -
Thromboxane A(2) Receptor Stimulation Enhances Microglial Interleukin-1β and NO Biosynthesis Mediated by the Activation of ERK Pathway
por: Yang, Wanlin, et al.
Publicado: (2016) -
Adjudin-preconditioned neural stem cells enhance neuroprotection after ischemia reperfusion in mice
por: Zhang, Tingting, et al.
Publicado: (2017) -
The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
por: Szczuko, Małgorzata, et al.
Publicado: (2021)